Elbit Medical Technologies Ltd. (ELBDF)
0.05
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 4.640M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 25.00% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | -- |
| Price to Book Value | 0.1187 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| Elbit Medical Technologies Ltd. is a holding company, which engages in the field of life sciences and medical equipment. It operates through the Insightec and Gamida Cell segments. The Insightec segment is involved research, development, production, and marketing of therapeutic medical systems based on a technological platform, which combines the use of a focused ultrasound beam and magnetic resonance imaging intended for performing non-invasive treatments on the human body. The Gamida Cell segment offers research and development of medical products based on stem cells derived mainly from umbilical cord blood for the purpose of bone marrow transplantation in patients with non-malignant blood diseases, blood or lymph node cancer, and metabolic genetic diseases. The company was founded on February 23, 1992 and is headquartered in Hod Ha'Sharon, Israel. |
| URL | N/A |
| Investor Relations URL | N/A |
| HQ State/Province | HaMerkaz |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | N/A |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Dec. 11, 2006 |
Profile
| Elbit Medical Technologies Ltd. is a holding company, which engages in the field of life sciences and medical equipment. It operates through the Insightec and Gamida Cell segments. The Insightec segment is involved research, development, production, and marketing of therapeutic medical systems based on a technological platform, which combines the use of a focused ultrasound beam and magnetic resonance imaging intended for performing non-invasive treatments on the human body. The Gamida Cell segment offers research and development of medical products based on stem cells derived mainly from umbilical cord blood for the purpose of bone marrow transplantation in patients with non-malignant blood diseases, blood or lymph node cancer, and metabolic genetic diseases. The company was founded on February 23, 1992 and is headquartered in Hod Ha'Sharon, Israel. |
| URL | N/A |
| Investor Relations URL | N/A |
| HQ State/Province | HaMerkaz |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Equity Style | N/A |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Dec. 11, 2006 |